Skip to main content
×
×
Home

Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations

  • Anna Gubbins (a1), John Lally (a1) (a2) and Colm McDonald (a1) (a2)
Abstract
Aims and method

To ascertain the prevalence of metabolic syndrome in individuals with chronic enduring mental illness attending community psychiatric day centres, and to identify the prevalence of individual cardiometabolic risk factors and the rate of screening for these abnormalities. One hundred participants with chronic enduring mental illness were recruited and investigated using physical assessments and comprehensive laboratory testing.

Results

Of the 100 participants recruited, 55% met the criteria for metabolic syndrome. There were similar prevalence rates between those with psychotic and non-psychotic disorders. Forty-four per cent of the patients had not been screened for metabolic parameters in the previous 12 months, and 43% of these met criteria for metabolic syndrome.

Clinical implications

Chronic enduring mental illness is associated with high prevalence rates of metabolic syndrome regardless of diagnosis or use of antipsychotic medication. A substantial proportion of this standard cohort of patients attending day centres carry cardiovascular risk factors that remain unidentified, but should be screened for and intensively managed.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
John Lally (john.lally@nuigalway.ie)
References
Hide All
1 Brown, S, Barraclough, B, Inskip, H. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–7.
2 Angst, F, Stassen, HH, Clayton, PJ, Angst, J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord 2002; 68: 167–81.
3 Sukanta, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123–31.
4 Brown, S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502–8.
5 Hoang, U, Stewart, R, Goldacre, MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ 2011; 343: d5422.
6 De Hert, M, Dekker, JM, Wood, D, Kahl, KG, Holt, RIG, Möller, HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009; 24: 412–24.
7 Alberti, KGMM, Zimmet, P, Shaw, J. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366: 1059–62.
8 Khatana, SAM, Kane, J, Taveira, TH, Bauer, MS, Wen-Chih, W. Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One 2011; 6: 18.
9 Daumit, G, Goff, D, Meyer, J, Davis, V, Nasrallah, H, McEvoy, J, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 2008; 105: 175–87.
10 Umbricht, DSG, Pollack, S, Kane, JM. Clozapine and weight gain. J Clin Psychiatry 1994; 55: 157–60.
11 Allison, DB, Mentore, JL, Heo, M, Chandler, LP, Cappelleri, JC, Infante, MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–96.
12 Akhtar, S, Kelly, C, Gallagher, A, Petrie, JR. Newer antipsychotic agents, carbohydrate metabolism and cardiovascular risk. Br J Diab Vasc Dis 2004; 4: 303–9.
13 Newcomer, JW. Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs 2005; 19: 193.
14 Krane-Gartiser, K, Breum, L, Glümrr, C, Linneberg, A, Madsen, M, Køster, A, et al. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Nord J Psychiatry 2011; 65: 345–52.
15 Correll, CU, Druss, BG, Lombardo, I, O'Gorman, C, Harnett, JP, Sanders, KN, et al. Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients. Psychiatr Serv 2010; 61: 892–8.
16 Gumber, R, Abbas, M, Minajagi, M. Monitoring the metabolic side-effects of atypical antipsychotics. Psychiatrist 2010; 34: 390–5.
17 World Health Organization. International Statistical Classification of Diseases and Related Health Problems (10th revision) (ICD-10). WHO, 1992.
18 British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. BMJ Group, Pharmaceutical Press.
19 Yorston, G, Pinney, A. Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatr Bull 2000; 24: 130–2.
20 Nathan, DM, Balkau, B, Bonora, E, Borch-Johnsen, K, Buse, JB, Colagiuri, S, et al. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. CPD Bull Clin Biochem 2010; 10: 2533.
21 Villegas, R, Perry, IJ, Creagh, D, Hinchion, R, O'Halloran, D. Prevalence of the metabolic syndrome in middle-aged men and women. Diab Care 2003; 26: 3198–9.
22 Ahmed, M, Hussain, I, O'Brien, SM, Dineen, B, Griffin, D, McDonald, C. Prevalence and associations of the metabolic syndrome among patients prescribed clozapine. Ir J Med Sci 2008; 177: 205–10.
23 Mackin, P, Bishop, D, Watkinson, H, Gallagher, P, Ferrier, IN. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry 2007; 191: 23–9.
24 Vinberg, M, Madsen, M, Breum, L, Kessing, LV, Fink-Jensen, A. Metabolic syndrome in a cohort of affectively ill patients, a naturalistic study. Nord J Psychiatry 2012; 66: 142–5.
25 John, AP, Koloth, R, Dragovic, M, Lim, SCB. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Australia 2009; 190: 176–9.
26 De Hert, M, van Winkel, R, Van Eyck, D, Hanssens, L, Wampers, M, Scheen, A, et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health 2006; 2: 14.
27 Kendrick, T. Management of people with schizophrenia in primary care. Adv Psychiatr Treat 1998; 4: 4652.
28 Bainbridge, E, Gallagher, A, McDonald, G, McDonald, C, Ahmed, M. General practitioners' attitudes on who should manage metabolic dysregulations associated with antipsychotics. Psychiatrist 2011; 35: 213–5.
29 De Hert, M, Vancampfort, D, Correll, CU, Mercken, V, Peuskens, J, Sweers, K, et al. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 2011; 199: 99105.
30 Tosh, G, Clifton, A, Bachner, M. General physical health advice for people with serious mental illness. Cochrane Database Syst Rev 2011; 2: CD008567.
31 De Hert, M, Schreurs, V, Vancampfort, D, Van Winkel, R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009; 8: 1522.
32 Holt, RIG, Abdelrahman, T, Hirsch, M, Dhesi, Z, George, T, Blincoe, T, et al. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol 2010; 24: 867–73.
33 Evans, S, Newton, R, Higgins, S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry 2005; 39: 479–86.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 1758-3209
  • EISSN: 1758-3217
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 20 *
Loading metrics...

Abstract views

Total abstract views: 70 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 22nd July 2018. This data will be updated every 24 hours.

Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations

  • Anna Gubbins (a1), John Lally (a1) (a2) and Colm McDonald (a1) (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *